$79.42
2.743.57%
Last update: Nov 2, 4:00 PM
iRadimed Corp
IRMDNASDAQ
iRadimed (IRMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
iRadimed (IRMD) last issued guidance on October 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $2.07 - $2.11, compared to a consensus EPS estimate of $2.09. iRadimed also guided revenue in the range of $91.6M - $93.1M for the period.
Compared to prior guidance, iRadimed lowered its EPS outlook from a previous range of $2.09 - $2.24. On the revenue side, the company lowered its revenue forecast from a prior range of $91M - $96M.
iRadimed has issued 41 guidance updates between November 3, 2022 and October 30, 2026. During this period, the company raised its outlook 16 times and lowered it 16 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.54 | $0.44 | $0.44 | $0.46 |
| Actual | $0.55 | $0.46 | $0.49 | $0.54 |
| Surprise | +1.85% | +4.55% | +11.4% | +17.4% |
| Revenue | ||||
| Estimate | $23.4M | $20.4M | $21.4M | $21.7M |
| Actual | $24.2M | $20.5M | $22.0M | $22.7M |
| Surprise | +3.28% | +0.57% | +2.81% | +4.70% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.62 | $0.58 |
| Revenue | ||
| Consensus | $26.2M | $25.0M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $0.55 | $0.54 | 1.85 % |
| Q2 | Jul 31, 2026 | $0.46 | $0.44 | 4.55 % |
| Q1 | May 1, 2026 | $0.49 | $0.44 | 11.4 % |
| Q4 | Feb 10, 2026 | $0.54 | $0.46 | 17.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $24.20M | $23.43M | 3.28 % |
| Q2 | Jul 31, 2026 | $20.47M | $20.35M | 0.57 % |
| Q1 | May 1, 2026 | $21.98M | $21.38M | 2.81 % |
| Q4 | Feb 10, 2026 | $22.69M | $21.67M | 4.70 % |
